1J88 image
Deposition Date 2001-05-20
Release Date 2001-08-29
Last Version Date 2024-11-13
Entry Detail
PDB ID:
1J88
Keywords:
Title:
HUMAN HIGH AFFINITY FC RECEPTOR FC(EPSILON)RI(ALPHA), TETRAGONAL CRYSTAL FORM 1
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.20 Å
R-Value Free:
0.31
R-Value Work:
0.26
R-Value Observed:
0.26
Space Group:
P 43
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:HIGH AFFINITY IMMUNOGLOBULIN EPSILON RECEPTOR ALPHA-SUBUNIT
Gene (Uniprot):FCER1A
Chain IDs:A, B, C, D, E
Chain Length:172
Number of Molecules:5
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN E ASN GLYCOSYLATION SITE
Ligand Molecules
Primary Citation
The analysis of the human high affinity IgE receptor Fc epsilon Ri alpha from multiple crystal forms.
J.Mol.Biol. 311 1049 1062 (2001)
PMID: 11531339 DOI: 10.1006/jmbi.2001.4929

Abstact

We have solved the structure of the human high affinity IgE receptor, Fc epsilon RI alpha, in six different crystal forms, showing the structure in 15 different chemical environments. This database of structures shows no change in the overall shape of the molecule, as the angle between domains 1 and 2 (D1 and D2) varies little across the ensemble. However, the receptor has local conformational variability in the C' strand of D2 and in the BC loop of D1. In every crystal form, a residue inserts between tryptophan residues 87 and 110, mimicking the position of a proline from the IgE ligand. The different crystal forms reveal a distribution of carbohydrates lining the front and back surfaces of the structure. An analysis of crystal contacts in the different forms indicates regions where the molecule interacts with other proteins, and reveals a potential new binding site distal to the IgE binding site. The results of this study point to new directions for the design of molecules to inhibit the interaction of Fc epsilon RI alpha with its natural ligand and thus to prevent a primary step in the allergic response.

Legend

Protein

Chemical

Disease

Primary Citation of related structures